Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).


Journal

ESMO open
ISSN: 2059-7029
Titre abrégé: ESMO Open
Pays: England
ID NLM: 101690685

Informations de publication

Date de publication:
04 2021
Historique:
received: 13 11 2020
revised: 22 12 2020
accepted: 23 12 2020
pubmed: 9 2 2021
medline: 30 10 2021
entrez: 8 2 2021
Statut: ppublish

Résumé

Women represent an increasing proportion of the oncology workforce; however, globally this does not translate into leadership roles, reflecting disparities in career opportunities between men and women. The Spanish Society of Medical Oncology (SEOM) undertook a survey to investigate gender disparity in the Spanish oncology context. An online survey was made available to SEOM medical oncologists between February and May 2019. It included demographics, professional context and achievements, parenthood and family conciliation issues, workplace gender bias, and approaches to address disparities. Of the 316 eligible respondents, 71.5% were women, 59.5% were aged 45 or younger, and 66.1% had children. Among women, 12.4% were division or unit heads, compared with 45.5% of men, with most women (74.3%) being attending medical oncologists, compared with 45.5% of men. More males were professors (34.4% versus 14.2% of females), had a PhD (46.7% versus 28.8%), and/or had led clinical research groups (41.1% versus 9.7%). Spending time overseas after completing a residency was also more common for men than women (34.4% versus 20.4%). Professional satisfaction was similar between genders, driven primarily by patient care and intellectual stimulation. More women (40.7%) considered parenthood to have a strong negative impact on their career, compared with men (9.0%). Main perceived barriers to gender equality included a lack of work-life balance (72.6% women, 44.4% men), bias of peers and superiors (50.0% women, 18.9% men), and different career goals (41.2% women, 24.4% men). Preferred solutions included educational programs and scholarships (52.9%), communication and leadership training (35.8%), childcare at conferences (33.2%), and postmaternity return-to-work incentives (32.0%). There is a clear paucity of equal opportunities for female oncologists in Spain. This can be addressed by encouraging professional development and merit recognition particularly for younger female oncologists, and empowering women to be involved in management and leadership of institutions and professional societies.

Sections du résumé

BACKGROUND
Women represent an increasing proportion of the oncology workforce; however, globally this does not translate into leadership roles, reflecting disparities in career opportunities between men and women. The Spanish Society of Medical Oncology (SEOM) undertook a survey to investigate gender disparity in the Spanish oncology context.
DESIGN
An online survey was made available to SEOM medical oncologists between February and May 2019. It included demographics, professional context and achievements, parenthood and family conciliation issues, workplace gender bias, and approaches to address disparities.
RESULTS
Of the 316 eligible respondents, 71.5% were women, 59.5% were aged 45 or younger, and 66.1% had children. Among women, 12.4% were division or unit heads, compared with 45.5% of men, with most women (74.3%) being attending medical oncologists, compared with 45.5% of men. More males were professors (34.4% versus 14.2% of females), had a PhD (46.7% versus 28.8%), and/or had led clinical research groups (41.1% versus 9.7%). Spending time overseas after completing a residency was also more common for men than women (34.4% versus 20.4%). Professional satisfaction was similar between genders, driven primarily by patient care and intellectual stimulation. More women (40.7%) considered parenthood to have a strong negative impact on their career, compared with men (9.0%). Main perceived barriers to gender equality included a lack of work-life balance (72.6% women, 44.4% men), bias of peers and superiors (50.0% women, 18.9% men), and different career goals (41.2% women, 24.4% men). Preferred solutions included educational programs and scholarships (52.9%), communication and leadership training (35.8%), childcare at conferences (33.2%), and postmaternity return-to-work incentives (32.0%).
CONCLUSION
There is a clear paucity of equal opportunities for female oncologists in Spain. This can be addressed by encouraging professional development and merit recognition particularly for younger female oncologists, and empowering women to be involved in management and leadership of institutions and professional societies.

Identifiants

pubmed: 33556897
pii: S2059-7029(21)00002-8
doi: 10.1016/j.esmoop.2021.100048
pmc: PMC7872979
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100048

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors declare no potential conflicts of interest.

Auteurs

E Elez (E)

Vall d'Hebron Institute of Oncology (VHIO), Medical Oncology Department, Barcelona, Spain.

F Ayala (F)

Hospital Universitario Morales Meseguer, Murcia, Spain.

E Felip (E)

Hospital Universitario Vall D'Hebron, Barcelona, Spain.

R García Campelo (R)

Complexo Hospitalario Universitario, A Coruña, Spain.

R García Carbonero (R)

Hospital Universitario 12 de Octubre, Madrid, Spain.

J García Donás (J)

Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain.

A González Del Alba (A)

Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

E González Flores (E)

Hospital Universitario Virgen de las Nieves, Granada, Spain.

J Hidalgo (J)

Hospital Lluis Alcanyís de Xativa, Valencia, Spain.

D Isla (D)

Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

M Majem (M)

Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.

Á Rodríguez Lescure (Á)

Hospital General Universitario de Elche, Alicante, Spain.

M J Safont (MJ)

Consorcio Hospital General Universitario, Valencia, Spain.

A Santaballa (A)

Hospital Universitari I Politècnic la Fe, Valencia, Spain.

G Villacampa (G)

Vall d'Hebron Institute of Oncology (VHIO), Medical Oncology Department, Barcelona, Spain.

R Vera (R)

Complejo Hospitalario de Navarra, Pamplona, Spain.

P Garrido (P)

Hospital Universitario Ramón y Cajal, Madrid, Spain. Electronic address: pilargarridol@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH